MeVis Medical Solutions AG (ETR:M3V)

ETR:M3V Statistics

Total Valuation

ETR:M3V has a market cap or net worth of EUR 47.32 million. The enterprise value is 44.75 million.

Market Cap	47.32M
Enterprise Value	44.75M

Important Dates

The next estimated earnings date is Thursday, January 29, 2026.

Earnings Date	Jan 29, 2026
Ex-Dividend Date	Mar 26, 2025

Share Statistics

ETR:M3V has 1.82 million shares outstanding.

Current Share Class	1.82M
Shares Outstanding	1.82M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	21.70%
Float	479,388

Valuation Ratios

The trailing PE ratio is 11.00.

PE Ratio	11.00
Forward PE	n/a
PS Ratio	2.84
PB Ratio	2.65
P/TBV Ratio	2.65
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	10.40
EV / Sales	2.69
EV / EBITDA	12.72
EV / EBIT	13.29
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.21

Current Ratio	4.21
Quick Ratio	3.70
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 24.14% and return on invested capital (ROIC) is 21.49%.

Return on Equity (ROE)	24.14%
Return on Assets (ROA)	8.64%
Return on Invested Capital (ROIC)	21.49%
Return on Capital Employed (ROCE)	15.29%
Weighted Average Cost of Capital (WACC)	3.20%
Revenue Per Employee	145,927
Profits Per Employee	37,745
Employee Count	114
Asset Turnover	0.68
Inventory Turnover	n/a

Taxes

In the past 12 months, ETR:M3V has paid 117,228 in taxes.

Income Tax	117,228
Effective Tax Rate	2.65%

Stock Price Statistics

The stock price has increased by +2.36% in the last 52 weeks. The beta is -0.19, so ETR:M3V's price volatility has been lower than the market average.

Beta (5Y)	-0.19
52-Week Price Change	+2.36%
50-Day Moving Average	24.90
200-Day Moving Average	25.12
Relative Strength Index (RSI)	74.87
Average Volume (20 Days)	182

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ETR:M3V had revenue of EUR 16.64 million and earned 4.30 million in profits. Earnings per share was 2.36.

Revenue	16.64M
Gross Profit	5.93M
Operating Income	3.37M
Pretax Income	4.42M
Net Income	4.30M
EBITDA	3.52M
EBIT	3.37M
Earnings Per Share (EPS)	2.36

Balance Sheet

The company has 2.57 million in cash and n/a in debt, with a net cash position of 2.57 million or 1.41 per share.

Cash & Cash Equivalents	2.57M
Total Debt	n/a
Net Cash	2.57M
Net Cash Per Share	1.41
Equity (Book Value)	17.83M
Book Value Per Share	9.79
Working Capital	5.04M

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 35.62%, with operating and profit margins of 20.25% and 25.87%.

Gross Margin	35.62%
Operating Margin	20.25%
Pretax Margin	26.57%
Profit Margin	25.87%
EBITDA Margin	21.16%
EBIT Margin	20.25%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.95, which amounts to a dividend yield of 3.65%.

Dividend Per Share	0.95
Dividend Yield	3.65%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	3.65%
Earnings Yield	9.09%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ETR:M3V has an Altman Z-Score of 6.45 and a Piotroski F-Score of 4.

Altman Z-Score	6.45
Piotroski F-Score	4